MoneyWorks4Me

Colinz Laboratories - Quaterly Results

31 Jul 2024 Evaluate
The sales declined to Rs. 17.47 millions for the June 2024 quarter as compared to Rs. 18.99 millions during the corresponding quarter last year.A humble growth in net profit of 12.30% reported in the quarter ended June 2024 to Rs. 1.37  millions from Rs. 1.22 millions.Operating Profit saw a handsome growth to 2.26 millions from 1.95 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 17.47 18.99 -8.00 17.47 18.99 -8.00 70.30 71.55 -1.75
Other Income 0.67 0.44 52.27 0.67 0.44 52.27 2.75 1.72 59.88
PBIDT 2.26 1.95 15.90 2.26 1.95 15.90 8.17 7.81 4.61
Interest 0.09 0.08 12.50 0.09 0.08 12.50 0.37 0.52 -28.85
PBDT 2.17 1.87 16.04 2.17 1.87 16.04 7.80 7.29 7.00
Depreciation 0.32 0.33 -3.03 0.32 0.33 -3.03 1.30 1.29 0.78
PBT 1.85 1.54 20.13 1.85 1.54 20.13 6.50 6.00 8.33
TAX 0.48 0.32 50.00 0.48 0.32 50.00 1.64 1.42 15.49
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.12 -0.16 -25.00
PAT 1.37 1.22 12.30 1.37 1.22 12.30 4.86 4.58 6.11
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 12.94 10.27 25.98 12.94 10.27 25.98 11.62 10.92 6.47
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..